Health Policy
Feature
Court strikes down Trump’s conscience rule
The measure would have allowed clinicians to refuse to provide medical care to patients for religious or moral reasons.
Commentary
How Do Drug Shortages Affect Dermatologists?
Drug shortages have the potential to diminish health outcomes; therefore, it is important for dermatologists to be aware of current shortages...
News
FDA chief calls for release of all data tracking problems with medical devices
The FDA is “realizing that physicians who couldn’t see this data before were using devices that they wouldn’t have used if they had this data in...
Feature
FDA chief calls for stricter scrutiny of electronic health records
The government spent more than $36 billion over 10 years to switch to digital records. In that time, thousands of reports of deaths, injuries, and...
Conference Coverage
MedPAC puts Part B reference pricing, binding arbitration on the table
The reference pricing policy would set a maximum payment rate for a group of drugs with similar health effects based on the minimum, median, or...
Feature
Prior authorization an increasing burden
Insurers are not following the 2018 consensus statement on improving the prior authorization process, the AMA says.
Latest News
Big pharma says it can’t drop drug list prices alone
The problem, they say, is the financial structure of drug delivery that ties list prices and their associated rebates to formulary placement.
Latest News
What does 'Medicare for all' mean?
Most respondents assumed that private insurance would be involved in some way.
From the Journals
Physician PAC dollars support candidates against gun regulation
The study found that the physician organization–affiliated PACs supported more candidates with an A rating from the National Rifle Association.
From the Journals
Health spending: Boomers will spike costs, but growing uninsured will soften their impact
CMS actuaries paint a complicated picture of health spending – and even predict a rise in physician wages.
Conference Coverage
McAneny: Transparency needed for meaningful talk on drug pricing
WASHINGTON – Transparency in marketing needs to be achieved in a way that does not hinder development of life-saving therapies, says AMA President...